Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Flutamide reduces hair growth better but has more side effects.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Certain hormone treatments can improve acne and related conditions in women.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The document concludes that more research is needed to fully understand the causes of PCOS.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.